Siler PANOWSKI
10Patents
1h-index
18Co-inventors
40Inventor score
Filing activity: Jan 31, 2019 → Jun 17, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11673953B2 | DLL3 targeting chimeric antigen receptors and binding agents | Chemistry; Metallurgy | 6 | Active |
| US11396551B2 | Chimeric antigen receptors targeting CD70 | Chemistry; Metallurgy | 1 | Active |
| US12043655B2 | Constitutively active chimeric cytokine receptors | Chemistry; Metallurgy | 0 | Active |
| US12152081B2 | Chimeric antigen receptors targeting CD70 | Chemistry; Metallurgy | 0 | Active |
| US11987634B2 | Antibodies specific for CD70 and their uses | Chemistry; Metallurgy | 0 | Active |
| US12215347B2 | Chimeric antigen receptors with enhanced signaling and activities and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11377500B2 | Antibodies specific for CD70 and their uses | Chemistry; Metallurgy | 0 | Active |
| US12404315B2 | Protease-activating CD45-gate CAR | Chemistry; Metallurgy | 0 | Active |
| US11786553B2 | Chimeric cytokine receptors bearing a PD-1 ectodomain | Chemistry; Metallurgy | 0 | Active |
| US12036243B2 | BCMA CAR-T cells with enhanced activities | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.